Showing results (1-10 of 790) with videos related to

Sort By:
Pageof 79
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 20, 2021
Age-adjusted incidence rates of synchronous liver metastases for stage IV colorectal cancer compared by sex, race, and age groupPhilip H G Ituarte, Rebecca Nelson, Michael P O'Leary, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 28, 2020
A Comparison of Liver-Directed Therapy and Systemic Therapy for the Treatment of Liver Metastases in Patients with Gastrointestinal Neuroendocrine Tumors: Analysis of the California Cancer RegistryJonathan Kessler, Gagandeep Singh, Philip H G Ituarte, et al.
Annals of Surgical Oncology|July 31, 2019
Lymphovascular Invasion Is Associated with Lymph Node Involvement in Small Appendiceal Neuroendocrine TumorsAndrew M Blakely, Mustafa Raoof, Philip H G Ituarte, et al.
Journal of Clinical Medicine|December 23, 2023
Liver-Directed Therapy in Neuroendocrine Neoplasms Metastatic to Both Liver and BoneKristen E Limbach, Kelly M Mahuron, Aaron T Scott, et al.
JAMA Surgery|March 16, 2017
Development and Validation of a Prognostic Score for Intrahepatic CholangiocarcinomaMustafa Raoof, Sinziana Dumitra, Philip H G Ituarte, et al.
Annals of Surgery|May 11, 2018
Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver TreatmentAaron Lewis, Mustafa Raoof, Philip H G Ituarte, et al.
Journal of Clinical Medicine|September 14, 2024
Liver Resection for Gastroenteropancreatic Neuroendocrine Tumors with Extrahepatic DiseaseKelly M Mahuron, Kristen E Limbach, Matthew C Hernandez, et al.
The American Surgeon|June 23, 2017
Evolving Role of Hepatic Resection for Metastatic Urologic MalignanciesJohn B Hamner, Mustafa Raoof, Sinziana Dumitra, et al.
Neuroendocrinology|August 12, 2019
Lymphovascular Invasion Predicts Lymph Node Involvement in Small Pancreatic Neuroendocrine TumorsAndrew M Blakely, Kelly J Lafaro, Daneng Li, et al.
Surgery|February 27, 2021
Does surgery provide a survival advantage in non-disseminated poorly differentiated gastroenteropancreatic neuroendocrine neoplasms?Lucas W Thornblade, Susanne G Warner, Laleh Melstrom, et al.
Pageof 79